Skip to content

A Study on the Link Between Digestive and Mental Health in IBS and the Role of Ayurvedic Treatment

An epidemiological study to assess the association of Annavaha Srotodushti with Manovaha Srotodushti in Vatika Grahani with special reference to Irritable Bowel Syndrome and therapeutic trial of Rasaparpati and Saraswata Churna in Vatika Grahani - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087809
Enrollment
60
Registered
2025-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having clinical signs and symptoms of Vatika Grahani as per Charaka Chikitsa 15th chapter. .Patients having sign and symptoms of IBS as per Rome 4 Criteria

Exclusion criteria

Exclusion criteria: Patient who has a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia. Pregnant or lactating women. Alcoholics and drug abusers. Mixed infection with the parasites like round worms, hook worms etc. Patients with bleeding per rectum. Patients with malignancy. Patients having asadhya lakshana and updrava of Grahani dosha. Patients having concomitant illness like HTN, DM-II, Amoebic dysentery. Ulcerative colitis, Malabsorption syndrome, Inflammatory Bowel Diseases & Intestinal tuberculosis, Lactase deficiency diarrhea.

Design outcomes

Primary

MeasureTime frame
Association of Annavaha Srotodusti with Manovaha Srotodusti in Vatika Grahani with special reference to Irritable Bowel Syndrome. Efficacy of Rasparpati and Saraswata Churna in Vatika Grahani with special reference to Irritable Bowel Syndrome. Timepoint: At The End Of The Study

Secondary

MeasureTime frame
Change in the symptoms of Vatika Grahani with special reference to Irritable Bowel Syndrome. Change in questionnaire on Manas pariksha bhava and agni dusti Changes in IBS Severity Score Scale. Change in lab parameters â?? C.B.C, Lipid profile, LFT, RFT Timepoint: 30 days

Countries

India

Contacts

Public ContactSurendra Kumar Sharma

institute

drsksm31@reddifmail.com9414361874

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026